Hong Kong Stock Alert | KLN (00636) Surges Over 10% in Early Trading as Company Selected as Strategic Fourth-Party Logistics Partner by Healthquest Pharma

Stock News
Aug 20

KLN (00636) surged over 10% in early trading. As of press time, the stock was up 7.26% to HK$9.45, with trading volume reaching HK$33.14 million.

On the news front, KLN announced that its pharmaceutical logistics subsidiary KLN Pharma has been appointed by Healthquest Pharma (Hong Kong) as the fourth-party logistics service provider in Hong Kong. Under the agreement, KLN Pharma will comprehensively manage Healthquest Pharma's supply chain, providing logistics solutions that meet temperature-controlled and time-sensitive requirements.

This collaboration encompasses comprehensive logistics services, including inbound logistics, inventory management, order fulfillment, marketing logistics, distribution, and regulatory support for Healthquest Pharma's diversified cardiovascular product portfolio.

It is noteworthy that Kerry Logistics officially rebranded to "KLN" in April this year. Regarding the rebranding rationale, the company's board explained that since SF Holdings Co., Ltd. completed its partial takeover offer in 2021, the company has been actively establishing a distinctive brand image and culture to facilitate the ownership transition. In recent years, the company has more widely adopted the "KLN" brand while reducing the frequency of using the "Kerry" name. The board believes that "KLN" has evolved into a household brand name that customers have become accustomed to.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10